French Innovative Leukemia Organisation

This study tested a chemotherapy-free treatment for people with previously untreated B-cell chronic lymphocytic leukemia (CLL). It combined two targeted drugs, ibrutinib and obinutuzumab, to control the disease. The goal was to see if this approach could reduce cancer cells to ve…

This study tested whether a combination of two targeted drugs (venetoclax and ibrutinib) works better than standard chemotherapy (FCR) for people with intermediate-risk chronic lymphocytic leukemia (CLL). About 120 fit adults who had not been treated before took part. The goal wa…

This study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to targeted drugs like ibrutinib and venetoclax. Researchers collected data on which treatments were used next and how well they worked. The goal was to understand the best way…